openPR Logo
Press release

Phantom Bullies Expands Legacy of XL/XXL American Bullies with Innovative Breeding Standards

12-30-2024 11:16 PM CET | Fashion, Lifestyle, Trends

Press release from: ABNewswire

Phantom Bullies Expands Legacy of XL/XXL American Bullies with

Leading Kennel Celebrates 15 Years of Expertise and Introduces Families to Exceptional Pitbull Puppies.
Phantom Bullies announces the expansion of its renowned XL/XXL American Bully and Pitbull breeding program, highlighting a dedication to quality, healthy bloodlines, and customer satisfaction. With more than 15 years of experience in producing top-tier puppies, the company's vision remains focused on uniting families with companions that transcend common standards and embody the essence of true excellence.

Phantom Bullies has built a reputation for consistency, integrity, and passion, drawing upon years of expertise to elevate the breeding of XL/XXL American Bullies. The kennel's array of puppies features diverse colors that include Merle, Lilac, and Blue varieties. Each puppy is derived from some of the most distinguished bloodlines in the industry, many of which have produced world champion dogs. Clients looking to adopt can expect full transparency as every puppy is health tested, and each sale includes a health guarantee to provide complete peace of mind.

Phantom Bullies credits its continued success to a deep-seated commitment to values and a personal connection with each family. This approach has gained admiration from various celebrity circles, including Rap artists, NBA athletes, and NFL players who endorse the kennel's dedication to excellence. The company's story is rooted in a profound passion for XL/XXL American Bullies, fueled by a vision that transcends the boundaries of standard breeding. Each dog is raised to showcase the finest traits of the breed, while offering families a companion that is both loyal and naturally inclined to become an integral part of the household.

"At Phantom Bullies, our vision is to redefine companionship while crafting a legacy that embodies exceptional care and rigorous breeding practices," commented a representative from the company. "Every Bullie is treated with the same level of devotion we expect in its future home. We remain committed to matching our puppies with loving families who recognize the profound impact a well-bred and well-cared-for dog can have."

Customer satisfaction underscores the company's reputation, with buyers routinely praising the supportive guidance offered throughout the adoption process. One recent customer expressed appreciation by stating, "You guys have been amazing. Seriously the best breeders and caretakers. This process was so great." Phantom Bullies encourages interested individuals to learn more about the available Pitbull puppies, confident that the kennel's approach will continue to attract families seeking a trusted and experienced breeder.

For more information visit www.PhantomBullies.com [http://www.PhantomBullies.com/].

Image: https://www.abnewswire.com/uploads/185d27ef76bd44b38125789b2835e082.png

About Phantom Bullies

Phantom Bullies is a professional XL/XXL American Bully and Pitbull breeder with over 15 years of experience in delivering dogs of exceptional quality. Located at the intersection of passion and expertise, the kennel is dedicated to fostering deep connections between families and extraordinary Bullies that represent the pinnacle of breeding excellence.

Media Contact
Company Name: Phantom Bullies
Contact Person: Media Relations
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=phantom-bullies-expands-legacy-of-xlxxl-american-bullies-with-innovative-breeding-standards]
Phone: 646-325-7754
Country: United States
Website: https://phantombullies.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Phantom Bullies Expands Legacy of XL/XXL American Bullies with Innovative Breeding Standards here

News-ID: 3800579 • Views:

More Releases from ABNewswire

PI3K Inhibitors Market Outlook: Roche, Novartis, and Emerging Biotechs Drive Competitive Innovation | DelveInsight
PI3K Inhibitors Market Outlook: Roche, Novartis, and Emerging Biotechs Drive Com …
DelveInsight's comprehensive analysis reveals robust growth potential in the PI3K inhibitors market across 7MM through 2034. Key players include Roche/Genentech (ITOVEBI), Novartis (PIQRAY), Gilead Sciences (ZYDELIG), Kazia Therapeutics (Paxalisib), Celcuity (Gedatolisib), and others, with expanding applications from hematological to solid tumor indications driving market momentum. PI3K Inhibitor Key Takeaways * PI3K Inhibitor market size projection: As per DelveInsight's analysis, the total market size of PI3K inhibitors in the 7MM is expected to
Bunion Market to Experience Growth by 2034, DelveInsight | Companies involved Syntellix, Treace Medical Concepts, Wright Medical Technology, Trilliant Surgical, Arthrosurface, Nextremity Solutions, Wr
Bunion Market to Experience Growth by 2034, DelveInsight | Companies involved Sy …
Bunion Treatment Market Report provides real-world prescription pattern analysis, emerging drugs, market share of individual therapies, and historical and forecasted 7MM Bunion market size from 2020 to 2034. The report also covers current Bunion treatment practices/algorithms and unmet medical needs to curate the best opportunities and assess the market's underlying potential. Emerging bunion therapies, including Magnezix CS and Lapiplasty 3-Dimensional Bunion Correction, are poised to boost market growth by providing innovative,
PDE4 Inhibitors Market Growth Accelerates Amid FDA Approvals, Pipeline Expansion, and Increasing Patient Pool | DelveInsight
PDE4 Inhibitors Market Growth Accelerates Amid FDA Approvals, Pipeline Expansion …
DelveInsight's PDE4 Inhibitor Market Report Reveals Significant Growth Through 2034, Led by Arcutis Biotherapeutics, Pfizer, Shionogi, Palisade Bio, UNION Therapeutics, Amgen, and Chiesi Farmaceutici with Key Assets Including ZORYVE, EUCRISA, OTEZLA, Zatolmilast, and PALI-2108 Across Multiple Inflammatory Conditions. DelveInsight Business Research's extensive market analysis titled "Phosphodiesterase-4 (PDE4) Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034 [https://www.delveinsight.com/report-store/phosphodiesterase-4-pde4-inhibitor-market-forecast?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]," provides a comprehensive insights into this rapidly evolving therapeutic class across
PD-L1 Inhibitors Market Dynamics: Robust Pipeline, Regulatory Wins, and Competitive Shifts Ahead | DelveInsight
PD-L1 Inhibitors Market Dynamics: Robust Pipeline, Regulatory Wins, and Competit …
DelveInsight's PD-L1 Inhibitors Market Analysis reveals $36B market across 7MM, dominated by Merck's KEYTRUDA and BMS's OPDIVO. Key players include Genentech, AstraZeneca, Regeneron, Pfizer. Emerging pipeline features sasanlimab, HLX43, balstilimab. Patent expirations in 2028 expected to reshape competitive landscape with biosimilar entry anticipated. PD-L1 Inhibitors Market Key Takeaways * Market size projection: As per DelveInsight's analysis, the total market size of PD-L1 inhibitors in the 7MM is expected to surge significantly from

All 5 Releases